Your browser doesn't support javascript.
loading
Open-label follow-on study evaluating the efficacy, safety, and quality of life with extended daily oral immunotherapy in children with peanut allergy.
Fernandez-Rivas, Montserrat; Vereda, Andrea; Vickery, Brian P; Sharma, Vibha; Nilsson, Caroline; Muraro, Antonella; Hourihane, Jonathan O'B; DunnGalvin, Audrey; du Toit, George; Blumchen, Katharina; Beyer, Kirsten; Smith, Alex; Ryan, Robert; Adelman, Daniel C; Jones, Stacie M.
Afiliação
  • Fernandez-Rivas M; Allergy Department, Hospital Clinico San Carlos, IdISSC, Madrid, Spain.
  • Vereda A; Aimmune Therapeutics, London, UK.
  • Vickery BP; Emory University School of Medicine, Atlanta, Georgia, USA.
  • Sharma V; Department of Paediatric Allergy and Immunology, Royal Manchester Children's Hospital, Manchester, UK.
  • Nilsson C; Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Sachs' Children and Youth Hospital, Stockholm, Sweden.
  • Muraro A; Food Allergy Referral Centre Veneto Region, Department of Woman and Child Health, Padua University Hospital, Padua, Italy.
  • Hourihane JO; Paediatrics and Child Health, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • DunnGalvin A; Infant Centre and Pediatrics and Child Health, University College Cork, and HRB Clinical Research Facility-Cork, Cork, Ireland.
  • du Toit G; Infant Centre and Pediatrics and Child Health, University College Cork, and HRB Clinical Research Facility-Cork, Cork, Ireland.
  • Blumchen K; Department of Pediatrics and Pediatric Infectious Diseases, Sechenov University, Moscow, Russia.
  • Beyer K; Guy's and St. Thomas' NHS Foundation Trust, London, UK.
  • Smith A; Division of Allergology, Pneumology and Cystic Fibrosis, Department of Children and Adolescent Medicine, Goethe University Frankfurt, Frankfurt, Germany.
  • Ryan R; Division of Pulmonology, Immunology and Critical Care Medicine, Department of Pediatrics, Charité Universtãtsmedizin Berlin, Berlin, Germany.
  • Adelman DC; Aimmune Therapeutics, Brisbane, California, USA.
  • Jones SM; Aimmune Therapeutics, London, UK.
Allergy ; 77(3): 991-1003, 2022 03.
Article em En | MEDLINE | ID: mdl-34320250
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hipersensibilidade a Amendoim / Hipersensibilidade Alimentar Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies Limite: Adolescent / Child / Child, preschool / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hipersensibilidade a Amendoim / Hipersensibilidade Alimentar Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies Limite: Adolescent / Child / Child, preschool / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article